Related Experiment Videos

Fibrosing alveolitis in an infant

J Riedler1, A Golser, I Huttegger

  • 1Dept of Paediatric Pulmonology, Kinderspital der Landeskrankenanstalten, Salzburg, Austria.

Insights

A rare infant lung disease caused interstitial fibrosis, initially unresponsive to standard treatments. Combination therapy with prednisone and azathioprine led to clinical improvement and normalized blood gases.

Area of Science:

  • Pediatric Pulmonology
  • Rare Pediatric Diseases
  • Interstitial Lung Disease

Background:

  • Infantile interstitial lung diseases present diagnostic challenges.
  • Early symptoms like cough and tachypnea can be non-specific.
  • Failure to thrive necessitates thorough investigation.

Observation:

  • A 3-month-old infant presented with persistent respiratory distress and failure to thrive.
  • Initial treatments with beta 2-agonists and antibiotics were ineffective.
  • Chest radiography revealed infiltrates, but physical findings of diffuse crackles were unexplained.

Findings:

  • Open lung biopsy demonstrated patchy interstitial fibrosis and thickened alveolar septa.
  • Initial prednisone therapy showed limited clinical benefit.
  • Combination therapy with azathioprine resulted in significant clinical improvement.

Implications:

  • This case highlights the importance of considering rare interstitial lung diseases in infants with persistent respiratory symptoms.
  • Prompt diagnosis and aggressive immunosuppressive therapy may be crucial for favorable outcomes.
  • The successful use of azathioprine suggests its potential role in managing similar pediatric interstitial lung diseases.

Related Concept Videos